RUBICON TECH INC

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 140% to $0.6041 after the company entered into a definitive merger agreement with GRI Bio. Immix Biopharma, Inc. (NASDAQ: IMMX) jumped 46% to $2.1695 after the company announced it has in-licensed BCMA-targeted next-generation CAR-T therapy NXC-201 with 85% ORR and 71% CR/sCR at the therapeutic dose from the first 20 patients in an ongoing phase 1b relapsed/refractory multiple myeloma ongoing clinical trial. Senti Biosciences, Inc. (NASDAQ: SNTI) rose 45% to $2.09 after dipping more than 21% on Tuesday. Avidity Biosciences, Inc. (NASDAQ: RNA) shares climbed 44.3% to $15.84 after the company announced AOC 1001 data from the preliminary assessment of the Phase 1/2 MARINA trial demonstrating the first-ever successful targeted delivery of RNA into muscle. BIMI International Medical, Inc. (NASDAQ: BIMI) gained 28.1% to $2.6649. BIMI reported entry into a material definitive agreement for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd. Wave Life Sciences Ltd. (NASDAQ: WVE) gained 21.1% to $5.80. SVB Leerink maintained WAVE Life Sciences with a Market Perform and raised the price target from $2 to $7. Kymera Therapeutics, Inc. (NASDAQ: KYMR) shares gained 21.4% to $31.38 after the company announced results from the Phase 1 clinical trial evaluating KT-474 in patients with HS and AD and Sanofi's decision to advance KT-474 into Phase 2 clinical trials. Aspen Group, Inc. (NASDAQ: ASPU) gained 17.4% to $0.41 after reporting strong quarterly sales. REV Group, Inc. (NYSE: REVG) jumped 17.2% to $15.57 as the company reported a fourth-quarter FY22 sales growth ...

Related tickers: OPGN, KYMR, DFLI, WVE, KSPN, GETR, ZVSA, SFR, SIOX, CYTK, REVG, NVVE, HLIT, AVDL, NCPL, RBCN, NXL, PBLA, CHTR, CVNA, WNW, QTEK, PCSA, YMTX, SMMT, ASPU, VS, VINC, DYN, PHCF, VLON, RNA, HROW, LVTX, UIHC, SQL, BHG, SNTI, HAPP, BTB, BIMI, OCG, ARQQ, OTIC, BXRX, MULN, DS, CRKN, IMMX.

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio. Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 71.2% to $0.2243 in pre-market trading after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. Versus Systems Inc. (NASDAQ: VS) rose 28% to $1.00 in pre-market trading after gaining around 7% on Tuesday. Versus Systems recently announced pricing of a $2.1 million public offering. Senti Biosciences, Inc. (NASDAQ: SNTI) rose 17.4% to $1.69 in pre-market trading after dipping more than 21% on Tuesday. Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 15.8% to $0.2839 in pre-market trading. Clovis Oncology, Inc. (NASDAQ: CLVS) rose 12.8% to $0.1503 in pre-market trading after dropping 34% on Tuesday. Clovis Oncology voluntarily initiated a Chapter 11 proceeding in the U.S. Bankruptcy Court and will seek to sell its assets through a court-supervised sales process. BIMI International Medical, Inc. (NASDAQ: BIMI) rose 12.8% to $2.35 in pre-market trading. BIMI reported entry into a material definitive agreement for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd. Cuentas Inc. (NASDAQ: CUEN) rose 12.2% to $0.3090 in pre-market trading after gaining 8% on Tuesday. Root, Inc. (NASDAQ: ROOT) rose 11.9% to $5.91 in pre-market trading. ...

Related tickers: ROOT, YI, CUEN, RBCN, HAPP, GAME, CRKN, CJJD, CLVS, KSPN, IVDA, AMST, SNTI, NCPL, BIMI, PBLA, DS, SCPS, HTGM, YMTX, OPGN, VLON, MCRB, LVTX, IQ, DDL, OBSV, REBN, VS.